Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Genetic modification of primary human B cells to model high-grade lymphoma.
Caeser R, Di Re M, Krupka JA, Gao J, Lara-Chica M, Dias JML, Cooke SL, Fenner R, Usheva Z, Runge HFP, Beer PA, Eldaly H, Pak HK, Park CS, Vassiliou GS, Huntly BJP, Mupo A, Bashford-Rogers RJM, Hodson DJ
Nat Commun. 2019 Oct 4;10(1):4543. doi: 10.1038/s41467-019-12494-x.
PubMed Article

Plasmids from Article

ID Plasmid Purpose
135305MSCV-BCL6-t2A-BCL2Overexpression of multiple human genes (BCL2 and BCL6)
135306MSCV-MYC-t2A-BCL2Overexpression of multiple human genes (BCL2 and MYC)
163611MSCV-BCL2Overexpression of human BCL2
163612phCMV-GALV-MTRRetro and Lentiviral transduction of primary human germinal center B cells
164662MSCV-Cas9-2A-BFPRetroviral introduction of Cas9 into mammalian cell line coupled to expression of blue fluorescent protein

Antibodies from Article